Action PAHC PHIBRO ANIMAL HEALTH CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Phibro Animal Health Corporation

Actions

PAHC

US71742Q1067

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 11/06/2024 		Varia. 5j. Varia. 1 janv.
16,75 USD -1,06 % Graphique intraday de Phibro Animal Health Corporation -2,50 % +44,65 %
09/05 Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024
08/05 Phibro Animal Health Corporation met à jour ses prévisions de résultats pour l'année 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Phibro Animal Health Corporation Releases Third Annual ESG Report, Connections that Advance Animal Health, Nutrition and Sustainability
Phibro Animal Health Corporation Releases Third Annual ESG Report: Connections that Advance Animal Health, Nutrition and Sustainability
Phibro Animal Health Corporation to Participate in Stifel Dental and Animal Health (Jaws & Paws) Conference
Phibro Animal Health : Third Quarter 2024 Transcript
Phibro Animal Health : Third Quarter – May 08, 2024 Presentation
Phibro Animal Health : Third Quarter 2024 Presentation
Phibro: Fiscal Q3 Earnings Snapshot
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29
Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 Revenue $263.2M, vs. Street Est of $253.7M
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance
Phibro Animal Health Corporation Updates Earnings Guidance for the Year 2024
Phibro Animal Health Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Phibro Animal Health Corporation Declares Quarterly Dividend
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on June 26, 2024
Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million
Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million
Zoetis to sell medicated feed additive portfolio to Phibro in $350 mln deal
Phibro Animal Health : to Acquire Zoetis’ MFAs Busines
Phibro Animal Health Corporation entered into a definitive agreement to acquire Medicated feed additive product portfolio, certain water soluble products and related assets of Zoetis Inc. for approximately $350 million.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PAHC
  4. Actualités Phibro Animal Health Corporation
  5. Autres langues